Editorial |

AIDS Drug Regimens That Are Worth Their Costs

David N. Rose, MD
JAMA. 1998;279(2):160-161. doi:10.1001/jama.279.2.160.
Text Size: A A A
Published online


The American public is justifiably celebrating the recent good news that opportunistic illnesses and deaths related to acquired immunodeficiency syndrome (AIDS) declined nationwide in 1996 for the first time since the pandemic began more than 15 years ago.1 These trends reflect advances in opportunistic infection prophylaxis and highly active antiretroviral therapy and interventions to prevent transmission of human immunodeficiency virus (HIV) infection. Published guidelines have provided thoughtful distillations of complex research results for widespread clinical use.26 Despite this, some population groups have not benefited from the new therapies. In fact, increased incidences of AIDS-related opportunistic illnesses in 1996 were experienced by black and Hispanic men and women with heterosexual exposures.1 The disparity in opportunistic infection trends between population groups most likely reflects differences in access to the full range of new therapies now available.7 Barriers to access are depriving many patients with HIV infection of life-extending health care.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 3

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles